Stock comparison

LLYvsVTRS

Eli Lilly and CovsViatris Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$917.65

-12.96%

Pharmaceuticals$884.0BNYSE

VTRS

Viatris Inc

$14.73

+26.98%

Pharmaceuticals$15.6BNASDAQ

60-day price, rebased to 100

LLY -11.52% · VTRS +11.85%

Round-by-round

LLY 4·VTRS 2

EdgeVTRS

Valuation upside

-70.70% vs +97.90% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 8.14 vs 0.89

EdgeLLY

Fundamental quality

Piotroski 8.00 vs 4.00 (of 9)

EdgeLLY

Growth + margins

Rule-of-40 53.90 vs 10.00

EdgeVTRS

60-day momentum

-11.52% vs +11.85% price return

EdgeLLY

Market-cap liquidity

$884.0B vs $15.6B

Verdict

Across6categories,LLYtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onLLYorVTRS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.